STTK Shattuck Labs Inc

Price (delayed)

$6.36

Market cap

$638.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.47

Enterprise value

$576.81M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 33

Shattuck Labs, Inc. is a biotechnology company specializing in the development of potential treatments for autoimmune/inflammatory diseases. The Company is developing a potentially first-in-class antibody for the treatment of inflammatory ...

Highlights
STTK's quick ratio has soared by 185% YoY and by 27% QoQ
The company's equity has surged by 120% QoQ
STTK's net income is up by 15% year-on-year but it is down by 5% since the previous quarter
Shattuck Labs's gross profit has shrunk by 67% YoY
STTK's revenue has dropped by 67% year-on-year

Key stats

What are the main financial stats of STTK

STTK stock price

How has the Shattuck Labs stock price performed over time
Intraday
-2.15%
1 week
8.16%
1 month
-15.54%
1 year
166.11%
YTD
74.25%
QTD
-8.36%

Financial performance

How have Shattuck Labs's revenue and profit performed over time
Revenue
$1M
Gross profit
$1M
Operating income
-$55.79M
Net income
-$52.57M
Gross margin
100%
Net margin
-5,256.8%
STTK's operating margin has dropped by 157% year-on-year and by 6% since the previous quarter
The net margin has dropped by 156% year-on-year and by 5% since the previous quarter
Shattuck Labs's gross profit has shrunk by 67% YoY
STTK's revenue has dropped by 67% year-on-year

Price vs fundamentals

How does STTK's price correlate with its fundamentals

Growth

What is Shattuck Labs's growth rate over time

Valuation

What is Shattuck Labs stock price valuation
P/E
N/A
P/B
2.31
P/S
825.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
576.81
Shattuck Labs's EPS has soared by 61% YoY and by 20% from the previous quarter
The company's equity has surged by 120% QoQ
The stock's price to book (P/B) is 48% more than its 5-year quarterly average of 1.6 but 16% less than its last 4 quarters average of 2.8
STTK's revenue has dropped by 67% year-on-year
STTK's price to sales (P/S) is 65% higher than its last 4 quarters average of 512.2

Efficiency

How efficient is Shattuck Labs business performance
Shattuck Labs's ROS has plunged by 156% YoY and by 5% from the previous quarter
The ROIC has soared by 63% YoY and by 55% QoQ
The ROE has grown by 47% year-on-year and by 28% since the previous quarter
STTK's return on assets is up by 43% year-on-year and by 27% since the previous quarter

Dividends

What is STTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STTK.

Financial health

How did Shattuck Labs financials performed over time
STTK's quick ratio has soared by 185% YoY and by 27% QoQ
STTK's current ratio has surged by 169% year-on-year and by 25% since the previous quarter
The debt is 99% smaller than the equity
The company's equity has surged by 120% QoQ
The company's debt to equity has shrunk by 75% YoY and by 50% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.